Subsidy Information and Financing Scheme SDLAmiloride & Hydrochlorothiazide Tablet, Amiloride Hydrochloride 5 mg + Hydrochlorothiazide 50 mg
Post Marketing Information DHCPL 23/07/2019 Risk of non-melanoma skin cancer associated with use of hydrochlorothiazide DHCPL 03/12/2018 Hydrochlorothiazide: Association with non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) [Sanofi] DHCPL 21/11/2018 Hydrochlorothiazide: Increased risk of non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma) DHCPL 14/11/2018 Hydrochlorothiazide: Association with non-melanoma skin cancer (basal cell carcinoma, squamous cell carcinoma)
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Tablet, Amiloride Hydrochloride 5 mg + Hydrochlorothiazide 50 mg Ng Teng Fong General Hospital National University Hospital